Defined inflammatory states in astrocyte cultures: Correlation with susceptibility towards CD95-driven apoptosis

Journal of Neurochemistry

Volumn 88, Issue 1, 2004, Pages 181-193

  Falsig, Jeppe ^a   Latta, Markus ^b   Leist, Marcel ^a  

^a H LUNDBECK A S   (Denmark)

^b UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

Apoptosis; Astrocyte; CD95; Inflammation; Nitric oxide; P38

Indexed keywords

CASPASE; CASPASE 8; CYCLOOXYGENASE 2; FAS ANTIBODY; FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL CELL; APOPTOSIS; ARTICLE; ASTROCYTE; CELL CULTURE; CELL TRANSFORMATION; ENZYME ACTIVATION; IMMUNOCYTOCHEMISTRY; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; UPREGULATION;

ANIMALIA; MURINAE;

EID: 0346733034     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2004.02144.x     Document Type: Article

References (71)

1. Barone F. C., Irving E. A., Ray A. M. et al. (2001) Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia. Med. Res. Rev. 21, 129-145.
2. Becher B., D'Souza S. D., Troutt A. B. and Antel J. P. (1998) Fas expression on human fetal astrocytes without susceptibility to fas-mediated cytotoxicity. Neuroscience 84, 627-634.
3. Bechmann I., Mor G., Nilsen J., Eliza M., Nitsch R. and Naftolin F. (1999) FasL (CD95L, Apo1L) is expressed in the normal rat and human brain, evidence for the existence of an immunological brain barrier. Glia 27, 62-74.
4. Bechmann I., Lossau S., Steiner B., Mor G., Gimsa U. and Nitsch R. (2000) Reactive astrocytes upregulate Fas (CD95) and Fas ligand (CD95L) expression but do not undergo programmed cell death during the course of anterograde degeneration. Glia 32, 25-41.
5. Bechmann I., Steiner B., Gimsa U., Mor G., Wolf S., Beyer M., Nitsch R. and Zipp F. (2002) Astrocyte-induced T cell elimination is CD95 ligand dependent. J. Neuroimmunol. 132, 60-65.
6. Beer R., Franz G., Schopf M., Reindl M., Zelger B., Schmutzhard E., Poewe W. and Kampfl A. (2000) Expression of Fas and Fas ligand after experimental traumatic brain injury in the rat. J. Cereb. Blood Flow Metab. 20, 669-677.
7. Bonetti B. and Raine C. S. (1997) Multiple sclerosis: oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis. Ann. Neurol. 42, 74-84.
8. Bordin S. and Whitfield D. (2003) Cutting edge: proliferating fibroblasts respond to collagenous Clq with phosphorylation of p38 mitogen-activated protein kinase and apoptotic features. J. Immunol. 170, 667-671.
9. Bowman C. C., Rasley A., Tranguch S. L. and Marriott I. (2003) Cultured astrocytes express toll-like receptors for bacterial products. Glia 43, 281-291.
10. Cheema Z. F., Wade S. B., Sata M., Walsh K., Sohrabji F. and Miranda R. C. (1999) Fas/Apo [apoptosis]-1 and associated proteins in the differentiating cerebral cortex: induction of caspase-dependent cell death and activation of NF-kappaB. J. Neurosci. 19, 1754-1770.
11. Chen Y. and Swanson R. A. (2003) Astrocytes and brain injury. J. Cereb. Blood Flow Metab. 23, 137-149.
12. Chen J. J., Sun Y. and Nabel G. J. (1998) Regulation of the proinflammatory effects of Fas ligand (CD95L). Science 282, 1714-1717.
13. Choi C., Park J. Y., Lee J. et al. (1999) Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-alpha, or IFN-gamma. J. Immunol. 162, 1889-1895.
14. Choi C., Xu X., Oh J. W., Lee S. J., Gillespie G. Y., Park H., Jo H. and Benveniste E. N. (2001) Fas-induced expression of chemokines in human glioma cells: involvement of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase. Cancer Res. 61, 3084-3091.
15. Choi C., Gillespie G. Y., Van Wagoner N. J. and Benveniste E. N. (2002) Fas engagement increases expression of interleukin-6 in human glioma cells. J. Neurooncol. 56, 13-19.
16. Chung I. Y. and Benveniste E. N. (1990) Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta. J. Immunol. 144, 2999-3007.
17. Ciccarelli R., Ballerini P., Sabatino G., Rathbone M. P., D'Onofrio M., Caciagli F. and Di Iorio P. (2001) Involvement of astrocytes in purine-mediated reparative processes in the brain. Int. J. Dev. Neurosci. 19, 395-414.
18. D'Souza S. D., Bonetti B., Balasingam V., Cashman N. R., Barker P. A., Troutt A. B., Raine C. S. and Antel J. P. (1996) Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J. Exp. Med. 184, 2361-2370.
19. Da Silva J., Pierrat B., Mary J. L. and Lesslauer W. (1997) Blockade of p38 mitogen-activated protein kinase pathway inhibits inducible nitric-oxide synthase expression in mouse astrocytes. J. Biol. Chem. 272, 28373-28380.
20. Davidson W. F., Haudenschild C., Kwon J. and Williams M. S. (2002) T cell receptor ligation triggers novel nonapoptotic cell death pathways that are Fas-independent or Fas-dependent. J. Immunol. 169, 6218-6230.
21. Desbarats J., Birge R. B., Mimouni-Rongy M., Weinstein D. E., Palerme J. S. and Newell M. K. (2003) Fas engagement induces neurite growth through ERK activation and p35 upregulation. Nat. Cell Biol. 5, 118-125.
22. Dong Y. and Benveniste E. N. (2001) Immune function of astrocytes. Glia 36, 180-190.
23. Dorf M. E., Berman M. A., Tanabe S., Heesen M. and Luo Y. (2000) Astrocytes express functional chemokine receptors. J. Neuroimmunol. 111, 109-121.
24. Eddleston M. and Mucke L. (1993) Molecular profile of reactive astrocytes - implications for their role in neurologic disease. J. Neurosci. 54, 15-36.
25. Endoh M., Maiese K. and Wagner J. (1994) Expression of the inducible form of nitric oxide synthase by reactive astrocytes after transient global ischemia. Brain Res. 651, 92-100.
26. Ferrer I., Puig B., Krupinsk J., Carmona M. and Blanco R. (2001) Fas and Fas ligand expression in Alzheimer's disease. Acta Neuropathol. 102, 121-131.
27. Franz G., Beer R., Intemann D. et al. (2002) Temporal and spatial profile of Bid cleavage after experimental traumatic brain injury. J. Cereb. Blood Flow Metab. 22, 951-958.
28. French L. E., Hahne M., Viard I., Radlgruber G., Zanone R., Becker K., Muller C. and Tschopp J. (1996) Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J. Cell Biol. 133, 335-343.
29. Harrison M., Dunger A. M., Berg S., Mabley J., John N., Green M. H. and Green I. C. (1998) Growth factor protection against cytokine-induced apoptosis in neonatal rat islets of Langerhans: role of Fas. FEBS Lett. 435, 207-210.
30. Hensley K., Floyd R. A., Zheng N. Y. et al. (1999) p38 kinase is activated in the Alzheimer's disease brain. J. Neurochem. 72, 2053-2058.
31. Hentze H., Schwoebel F., Lund S., Keel M., Ertel W., Wendel A., Jaattela M., Leist M. and Kehl M. (2001) In vivo and in vitro evidence for extracellular caspase activity released from apoptotic cells. Biochem. Biophys. Res. Commun. 283, 1111-1117.
32. Hirst W. D., Young K. A., Newton R., Allport V. C., Marriott D. R. and Wilkin G. P. (1999) Expression of COX-2 by normal and reactive astrocytes in the adult rat central nervous system. Mol. Cell. Neurosci. 13, 57-68.
33. Hou S. T., Xie X., Baggley A., Park D. S., Chen G. and Walker T. (2002) Activation of the Rb/E2F1 pathway by the nonproliferative p38 MAPK during Fas (APO1/CD95)-mediated neuronal apoptosis. J. Biol. Chem. 277, 48764-48770.
34. Hua L. L., Zhao M. L., Cosenza M., Kim M. O., Huang H., Tanowitz H. B., Brosnan C. F. and Lee S. C. (2002) Role of mitogen-activated protein kinases in inducible nitric oxide synthase and TNFalpha expression in human fetal astrocytes. J. Neuroimmunol. 126, 180-189.
35. Kohji T. and Matsumoto Y. (2000) Coexpression of Fas/FasL and Bax on brain and infiltrating T cells in the central nervous system is closely associated with apoptotic cell death during autoimmune encephalomyelitis. J. Neuroimmunol. 106, 165-171.
36. van Landeghem F. K., Felderhoff-Mueser U., Moysich A., Stadelmann C., Obladen M., Bruck W. and Buhrer C. (2002) Fas (CD95/Apo-1)/Fas ligand expression in neonates with pontosubicular neuron necrosis. Pediatr Res. 51, 129-135.
37. Lee S. J., Zhou T., Choi C., Wang Z. and Benveniste E. N. (2000) Differential regulation and function of Fas expression on glial cells. J. Immunol. 164, 1277-1285.
38. Lehnardt S., Lachance C., Patrizi S., Lefebvre S., Follett P. L., Jensen F. E., Rosenberg P. A., Volpe J. J. and Vartanian T. (2002) The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J. Neurosci. 22, 2478-2486.
39. Leithauser F., Dhein J., Mechtersheimer G., Koretz K., Bruderlein S., Henne C., Schmidt A., Debatin K. M., Krammer P. H. and Moller P. (1993) Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab. Invest. 69, 415-429.
40. Li G. L., Farooque M. and Olsson Y. (2000) Changes of Fas and Fas ligand immunoreactivity after compression trauma to rat spinal cord. Acta Neuropathol. (Berl.) 100, 75-81.
41. Loihl A. K., Asensio V., Campbell I. L. and Murphy S. (1999) Expression of nitric oxide synthase (NOS)-2 following permanent focal ischemia and the role of nitric oxide in infarct generation in male, female and NOS-2 gene-deficient mice. Brain Res. 830, 155-164.
42. Maeda Y., Matsumoto M., Hori O., Kuwabara K., Ogawa S., Yan S. D., Ohtsuki T., Kinoshita T., Kamada T. and Stern D. M. (1994) Hypoxia/reoxygenation-mediated induction of astrocyte interleukin 6: a paracrine mechanism potentially enhancing neuron survival. J. Exp. Med. 180, 2297-2308.
43. Malipiero U., Frei K., Spanaus K. S., Agresti C., Lassmann H., Hahne M., Tschopp J., Eugster H. P. and Fontana A. (1997) Myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis is chronic/relapsing in perforin knockout mice, but monophasic in Fas- and Fas ligand-deficient lpr and gld mice. Eur. J. Immunol. 27, 3151-3160.
44. Martin-Villalba A., Herr I., Jeremias I., Hahne M., Brandt R., Vogel J., Schenkel J., Herdegen T. and Debatin K. M. (1999) CD95 ligand (Fas-L/APO-IL) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons. J. Neurosci. 19, 3809-3817.
45. Martin-Villalba A., Hahne M., Kleber S., Vogel J., Falk W., Schenkel J. and Krammer P. H. (2001) Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke. Cell Death Differ 8, 679-686.
46. Maslinska D., Wozniak R., Kaliszek A. and Modelska I. (1999) Expression of cyclooxygenase-2 in astrocytes of human brain after global ischemia. Folia Neuropathol. 37, 75-79.
47. Matsuyama T., Hata R., Tagaya M., Yamamoto Y., Nakajima T., Furuyama J., Wanaka A. and Sugita M. (1994) Fas antigen mRNA induction in postischemic murine brain. Brain Res. 657, 342-346.
48. Mezosi E., Yamazaki H., Bretz J. D., Wang S. H., Arscott P. L., Utsugi S., Gauger P. G., Thompson N. W. and Baker J. R. Jr (2002) Aberrant apoptosis in thyroid epithelial cells from goiter nodules. J. Clin. Encrinol. Metab. 87, 4264-4272.
49. Minagar A., Shapshak P., Fujimura R., Ownby R., Heyes M. and Eisdorfer C. (2002) The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders. HIV-associated dementia, Alzheimer disease, and multiple sclerosis. J. Neurol. Sci. 202, 13-23.
50. Molina-Holgado F., Lledo A. and Guaza C. (1995) Evidence for cyclooxygenase activation by nitric oxide in astrocytes. Glia 15, 167-172.
51. Molina-Holgado E., Ortiz S., Molina-Holgado F. and Guaza C. (2000) Induction of COX-2 and PGE (2) biosynthesis by IL-1beta is mediated by PKC and mitogen-activated protein kinases in murine astrocytes. Br J. Pharmacol. 131, 152-159.
52. de la Monte S. M., Sohn Y. K. and Wands J. R. (1997) Correlates of p53-and Fas (CD95)-mediated apoptosis in Alzheimer's disease. J. Neurol. Sci. 152, 73-83.
53. Moreau G., Leite-De-Moraes M., Ezine S., Di Santo J. P., Dy M. and Schneider E. (2001) Natural killer cell-dependent apoptosis of peripheral murine hematopoietic progenitor cells in response to Fas cross-linking: involvement of tumor necrosis factor-alpha. Hematopoiesis 97, 3069-3074.
54. Nagata S. and Golstein P. (1995) The Fas death factor. Science 267, 1449-1456.
55. Ortiz-Arduan A., Danoff T. M., Kalluri R., Gonzalez-Cuadrado S., Karp S. L., Elkon K., Egido J. and Neilson E. G. (1996) Regulation of Fas and Fas ligand expression in cultured murine renal cells and in the kidney during endotoxemia. Am. J. Physiol. 271, F1193-F1201.
56. Piao C. S., Che Y., Han P. L. and Lee J. K. (2002) Delayed and differential induction of p38 MAPK isoforms in microglia and astrocytes in the brain after transient global ischemia. Brain Res. Mol. Brain Res. 107, 137-144.
57. Quirk S. M., Harman R. M., Huber S. C. and Cowan R. G. (2000) Responsiveness of mouse corpora luteal cells to Fas antigen (CD95)-mediated apoptosis. Biol. Reprod. 63, 49-56.
58. Raoul C., Henderson C. E. and Pettmann B. (1999) Programmed cell death of embryonic motoneurons triggered through the Fas death receptor. J. Cell Biol. 147, 1049-1062.
59. Raoul C., Estevez A. G., Nishimune H., Cleveland D. W., deLapeyriere O., Henderson C. E., Haase G. and Pettmann B. (2002) Motoneuron death triggered by a specific pathway downstream of Fas. potentiation by ALS-linked SOD1 mutations. Neuron 35, 1067-1083.
60. Rensing-Ehl A., Frei K., Flury R., Matiba B., Mariani S. M., Weller M., Aebischer P., Krammer P. H. and Fontana A. (1995) Local Fas/APO-1 (CD95) ligand-mediated tumor cell killing in vivo. Eur. J. Immunol. 25, 2253-2258.
61. Riccioli A., Starace D., D'Alessio A., Starace G., Padula F., De Cesaris P., Filippini A. and Ziparo E. (2000) TNF-alpha and IFN-gamma regulate expression and function of the Fas system in the seminiferous epithelium. J. Immunol. 165, 743-749.
62. Saas P., Boucraut J., Quiquerez A. L., Schnuriger V., Perrin G., Desplat-Jego S., Bernard D., Walker P. R. and Dietrich P. Y. (1999) CD95 (Fas/Apo-1) as a receptor governing astrocyte apoptotic or inflammatory responses: a key role in brain inflammation? J. Immunol. 162, 2326-2333.
63. Saas P., Walker P. R., Quiquerez A. L., Chalmers D. E., Arrighi J. F., Lienard A., Boucraut J. and Dietrich P. Y. (2002) A self-defence mechanism of astrocytes against Fas-mediated death involving interleukin-8 and CXCR2. Neuroreport 13, 1921-1924.
64. Scaffidi C., Krammer P. H. and Peter M. E. (1999) Isolation and analysis of components of CD95 (APO-1/Fas) death-inducing signaling complex. Methods 17, 287-291.
65. Shin D. H., Lee E., Kim H. J., Kim S., Cho S. S., Chang K. Y. and Lee W. J. (2002) Fas ligand mRNA expression in the mouse central nervous system. J. Neuroimmunol. 123, 50-57.
66. Simmons M. L. and Murphy S. (1992) Induction of nitric oxide synthase in glial cells. J. Neurochem. 59, 897-905.
67. Sola C., Casal C., Tusell J. M. and Serratosa J. (2002) Astrocytes enhance lipopolysaccharide-induced nitric oxide production by microglial cells. Eur J. Neurosci. 16, 1275-1283.
68. Stoll G., Jander S. and Schroeter M. (1998) Inflammation and glial responses in ischemic brain lesions. Prog. Neurobiol. 56, 149-171.
69. Terrazzino S., Bauleo A., Baldan A. and Leon A. (2002) Peripheral LPS administrations up-regulate Fas and FasL on brain microglial cells: a brain protective or pathogenic event? J. Neuroimmunol. 124, 45-53.
70. Weinstein D. E. (1997) Isolation and purification of primary rodent astrocytes. Current Protocols in Neuroscience, 3.5.1-3.5.9. John Wiley and Sons Inc.
71. Wosik K., Becher B., Ezman A., Nalbantoglu J. and Antel J. P. (2001) Caspase 8 expression and signaling in Fas injury-resistant human fetal astrocytes. Glia 33, 217-224.